Clinical Trials Sponsored by FSK

Total 326 results

SK Life Science, Inc.

Completed

Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).

Diabetic Neuropathy, Painful | Diabetic Polyneuropathy | Diabetic Neuralgia | Diabetic Mononeuropathy
SK Chemicals Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

Endometriosis

Korea, Republic of
SK Life Science, Inc.

Completed

Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs as a Means of Predicting Drug-drug Interactions

Healthy

United States
SK Chemicals Co., Ltd.

Completed

Safety Study of NBP608 in Healthy Adult Volunteers

Immunization; Infection | Varicella Zoster

Korea, Republic of
SK Chemicals Co., Ltd.

Terminated

Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

Asthma

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Safety/Tolerability and Pharmacokinetic Study of SID142

Arterial Occlusive Diseases
SK Chemicals Co., Ltd.

Completed

Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation (YKP)

Irritable Bowel Syndrome | Constipation

Korea, Republic of
SK Life Science, Inc.

Completed

A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation

Chronic Constipation | Functional Constipation

United States
SK Chemicals Co., Ltd.

Completed

Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus

Erectile Dysfunction

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

Erosive Gastritis

Korea, Republic of
SK Life Science, Inc.

Completed

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Epilepsy | Epilepsies, Partial
SK Life Science, Inc.

Completed

Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Seizures
SK Life Science, Inc.

Completed

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Refractory Epilepsy

United States, Poland, United Kingdom, Spain, Netherlands, Russian Federation, Hungary, Argentina
SK Chemicals Co., Ltd.

Completed

Phase I Study to Investigate the Alcohol Interaction of SK3530

Erectile Dysfunction

Korea, Republic of
SK Chemicals Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Ischemic Stroke

Korea, Republic of
SK Life Science, Inc.

Recruiting

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Partial Epilepsy

Korea, Republic of, United States
SK Life Science, Inc.

Recruiting

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Primary Generalized Epilepsy

United States, Spain, Germany, Hungary, Korea, Republic of, Australia, Bulgaria, Czechia, Poland, Slovakia, Ukraine
SK Life Science, Inc.

Completed

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Partial Epilepsy

United States, Spain, Korea, Republic of, Serbia, Germany, Bulgaria, Argentina, Australia, Chile, Czechia, Hungary, Mexico, Poland, Russian Federation, Sweden, Thailand, Ukraine
SK Life Science, Inc.

Enrolling by invitation

Cenobamate Open-Label Extension Study for YKP3089C025

Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy

United States, Bulgaria, Czechia, Hungary, Poland, Slovakia, Ukraine
SK Life Science, Inc.

Terminated

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Advanced Solid Tumor

United States
SK Life Science, Inc.

Completed

Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment

Hepatic Impairment

Poland, Slovakia
SK Life Science, Inc.

Active, not recruiting

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

Partial Seizure | Focal Seizure

China, Japan, Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Osteoarthritis, Knee

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD

Parkinson Disease

Korea, Republic of
SK Plasma Co., Ltd.

Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Korea, Republic of
SK Life Science, Inc.

Approved for marketing

Cenobamate Expanded Access Program (EAP)

Partial Epilepsy
SK Plasma Co., Ltd.

Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Infants

Pneumococcal Infections

Korea, Republic of
SK Life Science, Inc.

Completed

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

Healthy Volunteer

United States, Canada
SK Chemicals Co., Ltd.

Completed

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines
SK Life Science, Inc.

Completed

A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia

Schizophrenia

United States
SK Chemicals Co., Ltd.

Completed

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Influenza, Human
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Influenza, Human
SK Chemicals Co., Ltd.

Completed

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

Drug Interaction Potentiation
SK Chemicals Co., Ltd.

Completed

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Hepatitis B

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

Influenza, Human
SK Chemicals Co., Ltd.

Completed

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Hypertension

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

Asthma

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Phase 1 Study of SK3530 to Investigate of the Effect of Food

Erectile Dysfunction
SK Life Science, Inc.

Terminated

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Epilepsy | Seizures
SK Life Science, Inc.

Completed

A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor

Essential Tremor, Movement Disorders
SK Life Science, Inc.

Completed

An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics

Diabetic Neuropathies
SK Life Science, Inc.

Terminated

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Seizures
SK Life Science, Inc.

Completed

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

Migraine Headaches

United States
SK Life Science, Inc.

Completed

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Epilepsy | Epilepsy, Complex Partial | Seizure Disorder | Complex Partial Seizures | Epilepsy, Focal
SK Chemicals Co., Ltd.

Completed

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Gout

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo

Healthy

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

Erectile Dysfunction

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension

Hypertension

Korea, Republic of
Mediforum Ltd., Co.
LSK Global Pharma Services Co. Ltd.

Recruiting

A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease (PM012-2b)

Mild Alzheimer Disease

Korea, Republic of

3

Subscribe